zur Startseite zur Hauptnavigation zum Hauptinhalt zum Kontaktformular
Gebro Pharma AG
Gebro Pharma AG
Grienmatt 2
4410 Liestal, CH
+41 61 926 88 33
+41 61 926 88 44
Keine Einträge gefunden


Gebro Pharma AG, Switzerland

Gebro Pharma AG is the Swiss subsidiary of the international successful Gebro Holding GmbH with its headquarters based in Fieberbrunn, Austria. Gebro is specialized in the distribution of high-quality medicinal products for both, Rx and OTC. Besides products from our parent company, we also distribute products that we exclusively do in-license for the Swiss market from our national and international partners.

  • Reference company for Rheumatology and Pain in the Swiss market
  • Strong market expertise and network, including KOLs in core competence areas and authorities
  • Successful performance and positive track record of alliances
  • Partner-oriented mind-set
  • In-house expertise to obtain and maintain marketing authorizations and positive reimbursement status in Switzerland
  • High priority and commitment in terms of investment and promotion given to each product
  • Result-oriented to maximize the potential of each product

Key Focus Areas

Our mission is to distribute innovative products and services which enhance our patients’ quality of life. Gebro is your partner of choice for innovative medicinal products and services in:

  • Rheumatology
  • Pain
  • Dermatology
  • Cough and Cold
  • Rare Diseases


Business Development

Gebro Pharma AG is continuously seeking for new, innovative products to extend its product portfolio. This includes not only existing but also additional therapeutic indications.

Gebro Pharma AG is partners an extensive expertise in the Swiss market with excellent access to local authorities and a huge salesforce network with doctors, hospitals and pharmacies.  We are experts when it comes to medical, marketing & sales, regulatory or logistic challenges.


What we are looking for:

  • Innovative medicinal products (Rx/OTX/OTC)
  • Unique products which are not yet available/commercialized in Switzerland
  • Generic products with a new indication, improved galenic or innovative packaging
  • In-Licensing, co-marketing, co-promotion opportunities
  • Products in late stage clinical development, ready to market or finished products
  • Commercialized products in other territories (EU, U.S., etc.)